These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37600513)

  • 1. Magnetic resonance imaging and neuropsychological findings for predicting of cognitive deterioration in memory clinic patients.
    Matsuda K; Shinohara M; Ii Y; Tabei KI; Ueda Y; Nakamura N; Hirata Y; Ishikawa H; Matsuyama H; Matsuura K; Satoh M; Maeda M; Momosaki R; Tomimoto H; Shindo A
    Front Aging Neurosci; 2023; 15():1155122. PubMed ID: 37600513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between behavioral and psychological symptoms and cerebral small vessel disease MRI findings in memory clinic patients.
    Shinohara M; Matsuda K; Ii Y; Tabei KI; Nakamura N; Hirata Y; Ishikawa H; Matsuyama H; Matsuura K; Maeda M; Tomimoto H; Shindo A
    Front Aging Neurosci; 2023; 15():1143834. PubMed ID: 37032819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertensive Arteriopathy and Cerebral Amyloid Angiopathy in Patients with Cognitive Decline and Mixed Cerebral Microbleeds.
    Ii Y; Ishikawa H; Matsuyama H; Shindo A; Matsuura K; Yoshimaru K; Satoh M; Taniguchi A; Matsuda K; Umino M; Maeda M; Tomimoto H
    J Alzheimers Dis; 2020; 78(4):1765-1774. PubMed ID: 33185609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between cortical microinfarcts and total small vessel disease burden in cerebral amyloid angiopathy on 3-Tesla magnetic resonance imaging.
    Ii Y; Ishikawa H; Shindo A; Matsuyama H; Matsuura K; Matsuda K; Yoshimaru K; Satoh M; Kogue R; Umino M; Maeda M; Tomimoto H
    Eur J Neurol; 2021 Mar; 28(3):794-799. PubMed ID: 33098163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebral Microbleeds and White Matter Hyperintensities are Associated with Cognitive Decline in an Asian Memory Clinic Study.
    Gyanwali B; Lui B; Tan CS; Chong EJY; Vrooman H; Chen C; Hilal S
    Curr Alzheimer Res; 2021; 18(5):399-413. PubMed ID: 34420506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging markers of cerebral amyloid angiopathy and hypertensive arteriopathy differentiate Alzheimer disease subtypes synergistically.
    Chen TB; Lee WJ; Chen JP; Chang SY; Lin CF; Chen HC
    Alzheimers Res Ther; 2022 Sep; 14(1):141. PubMed ID: 36180874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.
    Xiong L; Boulouis G; Charidimou A; Roongpiboonsopit D; Jessel MJ; Pasi M; Reijmer YD; Fotiadis P; Ayres A; Merrill E; Schwab K; Blacker D; Gurol ME; Greenberg SM; Viswanathan A
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):241-249. PubMed ID: 28318355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological Features of Microbleeds and Cortical Microinfarct Detected by High Resolution Magnetic Resonance Imaging.
    Ueda Y; Satoh M; Tabei K; Kida H; Ii Y; Asahi M; Maeda M; Sakuma H; Tomimoto H
    J Alzheimers Dis; 2016 May; 53(1):315-25. PubMed ID: 27163803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage.
    Boulouis G; Charidimou A; Jessel MJ; Xiong L; Roongpiboonsopit D; Fotiadis P; Pasi M; Ayres A; Merrill ME; Schwab KM; Rosand J; Gurol ME; Greenberg SM; Viswanathan A
    Neurology; 2017 Feb; 88(9):878-884. PubMed ID: 28130469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between total cerebral small vessel disease score and cognitive function in patients with vascular risk factors.
    Hosoya M; Toi S; Seki M; Saito M; Hoshino T; Yoshizawa H; Kitagawa K
    Hypertens Res; 2023 May; 46(5):1326-1334. PubMed ID: 36894746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical microinfarcts in patients with multiple lobar microbleeds on 3 T MRI.
    Ii Y; Maeda M; Ishikawa H; Ito A; Matsuo K; Umino M; Shindo A; Kida H; Satoh M; Niwa A; Taniguchi A; Tomimoto H
    J Neurol; 2019 Aug; 266(8):1887-1896. PubMed ID: 31049727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Predictive Values of Different Small Vessel Disease Scores on Clinical Outcomes in Mild ICH Patients.
    Xu T; Feng Y; Wu W; Shen F; Ma X; Deng W; Zhang B; Hu J; Fu Y
    J Atheroscler Thromb; 2021 Sep; 28(9):997-1008. PubMed ID: 33551444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of cerebral microbleeds: In vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment.
    Park JH; Seo SW; Kim C; Kim GH; Noh HJ; Kim ST; Kwak KC; Yoon U; Lee JM; Lee JW; Shin JS; Kim CH; Noh Y; Cho H; Kim HJ; Yoon CW; Oh SJ; Kim JS; Choe YS; Lee KH; Lee JH; Ewers M; Weiner MW; Werring DJ; Na DL
    Ann Neurol; 2013 May; 73(5):584-93. PubMed ID: 23495089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorrhage recurrence risk factors in cerebral amyloid angiopathy: Comparative analysis of the overall small vessel disease severity score versus individual neuroimaging markers.
    Boulouis G; Charidimou A; Pasi M; Roongpiboonsopit D; Xiong L; Auriel E; van Etten ES; Martinez-Ramirez S; Ayres A; Vashkevich A; Schwab KM; Rosand J; Goldstein JN; Gurol ME; Greenberg SM; Viswanathan A
    J Neurol Sci; 2017 Sep; 380():64-67. PubMed ID: 28870591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo neuroinflammation and cerebral small vessel disease in mild cognitive impairment and Alzheimer's disease.
    Low A; Mak E; Malpetti M; Passamonti L; Nicastro N; Stefaniak JD; Savulich G; Chouliaras L; Su L; Rowe JB; Markus HS; O'Brien JT
    J Neurol Neurosurg Psychiatry; 2020 Sep; 92(1):45-52. PubMed ID: 32917821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large Perivascular Spaces Visible on Magnetic Resonance Imaging, Cerebral Small Vessel Disease Progression, and Risk of Dementia: The Age, Gene/Environment Susceptibility-Reykjavik Study.
    Ding J; Sigurðsson S; Jónsson PV; Eiriksdottir G; Charidimou A; Lopez OL; van Buchem MA; Guðnason V; Launer LJ
    JAMA Neurol; 2017 Sep; 74(9):1105-1112. PubMed ID: 28715552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy.
    McCreary CR; Beaudin AE; Subotic A; Zwiers AM; Alvarez A; Charlton A; Goodyear BG; Frayne R; Smith EE
    Neuroimage Clin; 2020; 27():102280. PubMed ID: 32521475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
    Low A; Prats-Sedano MA; McKiernan E; Carter SF; Stefaniak JD; Nannoni S; Su L; Dounavi ME; Muniz-Terrera G; Ritchie K; Lawlor B; Naci L; Malhotra P; Mackay C; Koychev I; Ritchie CW; Markus HS; O'Brien JT
    Alzheimers Res Ther; 2022 Oct; 14(1):154. PubMed ID: 36224605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visuospatial dysfunction is associated with posterior distribution of white matter damage in non-demented cerebral amyloid angiopathy.
    Su Y; Fu J; Zhang Y; Xu J; Dong Q; Cheng X
    Eur J Neurol; 2021 Sep; 28(9):3113-3120. PubMed ID: 34157199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total small vessel disease burden and brain network efficiency in cerebral amyloid angiopathy.
    Valenti R; Reijmer YD; Charidimou A; Boulouis G; Martinez SR; Xiong L; Fotiadis P; Jessel M; Ayres A; Riley G; Pantoni L; Edip Gurol M; Greenberg SM; Viswanathan A
    J Neurol Sci; 2017 Nov; 382():10-12. PubMed ID: 29110998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.